• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全人群心血管疾病预防的效果和成本效益:建模研究。

Effectiveness and cost effectiveness of cardiovascular disease prevention in whole populations: modelling study.

机构信息

Health Economics Unit, Public Health Building, University of Birmingham, Birmingham B15 2TT, UK.

出版信息

BMJ. 2011 Jul 28;343:d4044. doi: 10.1136/bmj.d4044.

DOI:10.1136/bmj.d4044
PMID:21798967
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3145836/
Abstract

OBJECTIVE

To estimate the potential cost effectiveness of a population-wide risk factor reduction programme aimed at preventing cardiovascular disease.

DESIGN

Economic modelling analysis.

SETTING

England and Wales. Population Entire population. Model Spreadsheet model to quantify the reduction in cardiovascular disease over a decade, assuming the benefits apply consistently for men and women across age and risk groups.

MAIN OUTCOME MEASURES

Cardiovascular events avoided, quality adjusted life years gained, and savings in healthcare costs for a given effectiveness; estimates of how much it would be worth spending to achieve a specific outcome.

RESULTS

A programme across the entire population of England and Wales (about 50 million people) that reduced cardiovascular events by just 1% would result in savings to the health service worth at least £30m (€34m; $48m) a year compared with no additional intervention. Reducing mean cholesterol concentrations or blood pressure levels in the population by 5% (as already achieved by similar interventions in some other countries) would result in annual savings worth at least £80m to £100m. Legislation or other measures to reduce dietary salt intake by 3 g/day (current mean intake approximately 8.5 g/day) would prevent approximately 30,000 cardiovascular events, with savings worth at least £40m a year. Legislation to reduce intake of industrial trans fatty acid by approximately 0.5% of total energy content might gain around 570,000 life years and generate NHS savings worth at least £230m a year.

CONCLUSIONS

Any intervention that achieved even a modest population-wide reduction in any major cardiovascular risk factor would produce a net cost saving to the NHS, as well as improving health. Given the conservative assumptions used in this model, the true benefits would probably be greater.

摘要

目的

评估一项旨在预防心血管疾病的全人群危险因素降低计划的潜在成本效益。

设计

经济建模分析。

设置

英格兰和威尔士。人群:整个人群。模型:使用电子表格模型来量化十年内心血管疾病的减少量,假设该计划对不同年龄和风险组别的男性和女性都具有一致的益处。

主要结果测量指标

避免的心血管事件、获得的质量调整生命年以及特定效果的成本节约;实现特定结果的成本效益估计。

结果

在英格兰和威尔士(约 5000 万人)开展一项覆盖整个人群的计划,即使仅降低 1%的心血管事件,与不进行额外干预相比,每年也将为医疗服务节省至少 3000 万英镑(3400 万欧元;4800 万美元)。将人群的平均胆固醇浓度或血压水平降低 5%(已经在其他一些国家实施的类似干预措施已经实现了这一目标),每年将节省至少 8000 万至 1 亿英镑。通过立法或其他措施将每日盐摄入量减少 3 克(目前的平均摄入量约为 8.5 克/天),将预防约 3 万例心血管事件,每年可节省至少 4000 万英镑。立法将工业反式脂肪酸摄入量减少约 0.5%总能量含量,可能会增加约 57 万生命年,并为国民保健制度节省每年至少 2.3 亿英镑的费用。

结论

任何实现全人群主要心血管危险因素适度降低的干预措施都将为国民保健制度带来净成本节约,并改善健康状况。鉴于该模型使用了保守的假设,实际效益可能更大。

相似文献

1
Effectiveness and cost effectiveness of cardiovascular disease prevention in whole populations: modelling study.全人群心血管疾病预防的效果和成本效益:建模研究。
BMJ. 2011 Jul 28;343:d4044. doi: 10.1136/bmj.d4044.
2
The health gains and cost savings of dietary salt reduction interventions, with equity and age distributional aspects.减少膳食盐摄入干预措施在健康收益、成本节约以及公平性和年龄分布方面的情况。
BMC Public Health. 2016 May 23;16:423. doi: 10.1186/s12889-016-3102-1.
3
An economic evaluation of salt reduction policies to reduce coronary heart disease in England: a policy modeling study.减少英格兰盐摄入量以降低冠心病的经济评估:政策建模研究。
Value Health. 2014 Jul;17(5):517-24. doi: 10.1016/j.jval.2014.03.1722. Epub 2014 Jun 2.
4
Health and Economic Impacts of the National Menu Calorie Labeling Law in the United States: A Microsimulation Study.美国国家菜单卡路里标签法的健康与经济影响:一项微观模拟研究
Circ Cardiovasc Qual Outcomes. 2020 Jun;13(6):e006313. doi: 10.1161/CIRCOUTCOMES.119.006313. Epub 2020 Jun 4.
5
Estimated health benefits, costs, and cost-effectiveness of eliminating industrial trans-fatty acids in Australia: A modelling study.估计消除澳大利亚工业反式脂肪酸的健康效益、成本和成本效益:一项建模研究。
PLoS Med. 2020 Nov 2;17(11):e1003407. doi: 10.1371/journal.pmed.1003407. eCollection 2020 Nov.
6
Assessing long-term effectiveness and cost-effectiveness of statin therapy in the UK: a modelling study using individual participant data sets.评估英国他汀类药物治疗的长期有效性和成本效益:一项使用个体参与者数据集的建模研究。
Health Technol Assess. 2024 Dec;28(79):1-134. doi: 10.3310/KDAP7034.
7
Cost-effectiveness of financial incentives and disincentives for improving food purchases and health through the US Supplemental Nutrition Assistance Program (SNAP): A microsimulation study.通过美国补充营养援助计划(SNAP)提高食品购买和健康水平的经济激励和抑制措施的成本效益:一项微观模拟研究。
PLoS Med. 2018 Oct 2;15(10):e1002661. doi: 10.1371/journal.pmed.1002661. eCollection 2018 Oct.
8
Cost effectiveness of a government supported policy strategy to decrease sodium intake: global analysis across 183 nations.一项政府支持的降低钠摄入量政策策略的成本效益:对183个国家的全球分析
BMJ. 2017 Jan 10;356:i6699. doi: 10.1136/bmj.i6699.
9
Cost-effectiveness analysis of eliminating industrial and all trans fats in England and Wales: modelling study.消除英格兰和威尔士的工业和全反式脂肪的成本效益分析:建模研究。
J Public Health (Oxf). 2017 Sep 1;39(3):574-582. doi: 10.1093/pubmed/fdw095.
10
Future cost-effectiveness and equity of the NHS Health Check cardiovascular disease prevention programme: Microsimulation modelling using data from Liverpool, UK.英国国民保健制度健康检查心血管疾病预防计划的未来成本效益和公平性:使用英国利物浦数据的微观模拟建模。
PLoS Med. 2018 May 29;15(5):e1002573. doi: 10.1371/journal.pmed.1002573. eCollection 2018 May.

引用本文的文献

1
Neck circumference as a metabolic health marker among women with polycystic ovary syndrome (PCOS): a systematic review and meta-analysis.多囊卵巢综合征(PCOS)女性中颈围作为代谢健康标志物的系统评价和荟萃分析
Int J Obes (Lond). 2025 Apr 21. doi: 10.1038/s41366-025-01753-1.
2
Public health economic modelling in evaluations of salt and/or alcohol policies: a systematic scoping review.盐和/或酒精政策评估中的公共卫生经济建模:一项系统性综述
BMC Public Health. 2025 Jan 8;25(1):82. doi: 10.1186/s12889-024-21237-7.
3
[Cardiovascular prevention in Saxony-Anhalt : Necessity and new perspectives].[萨克森-安哈尔特州的心血管疾病预防:必要性与新视角]
Inn Med (Heidelb). 2024 Nov;65(11):1137-1146. doi: 10.1007/s00108-024-01789-x. Epub 2024 Oct 10.
4
Cost-effectiveness of a novel AI technology to quantify coronary inflammation and cardiovascular risk in patients undergoing routine coronary computed tomography angiography.一种新型人工智能技术在接受常规冠状动脉计算机断层扫描血管造影的患者中量化冠状动脉炎症和心血管风险的成本效益。
Eur Heart J Qual Care Clin Outcomes. 2025 Jun 23;11(4):434-444. doi: 10.1093/ehjqcco/qcae085.
5
Cardiovascular risk assessment using non-laboratory based WHO CVD risk prediction chart with respect to hypertension status among older Indian adults: insights from nationally representative survey.基于非实验室的世界卫生组织心血管疾病风险预测图表对高血压状况下的老年印度成年人进行心血管风险评估:来自全国代表性调查的见解。
Front Public Health. 2024 Sep 5;12:1407918. doi: 10.3389/fpubh.2024.1407918. eCollection 2024.
6
Interventions in the workplace to reduce risk factors for noncommunicable diseases: an umbrella review of systematic reviews of effectiveness.工作场所干预措施以减少非传染性疾病的风险因素:系统评价有效性的伞式综述。
J Occup Health. 2024 Jan 4;66(1). doi: 10.1093/joccuh/uiae044.
7
Risk estimation for the primary prevention of cardiovascular disease: considerations for appropriate risk prediction model selection.心血管疾病一级预防的风险评估:适当风险预测模型选择的考虑因素。
Lancet Glob Health. 2024 Aug;12(8):e1343-e1358. doi: 10.1016/S2214-109X(24)00210-9.
8
Using machine learning to predict acute myocardial infarction and ischemic heart disease in primary care cardiovascular patients.利用机器学习预测基层医疗心血管患者的急性心肌梗死和缺血性心脏病。
PLoS One. 2024 Jul 18;19(7):e0307099. doi: 10.1371/journal.pone.0307099. eCollection 2024.
9
Association of cardiovascular health and educational status in a screening cohort.心血管健康与筛查队列中教育程度的关系。
Cent Eur J Public Health. 2024 Mar;32(1):25-30. doi: 10.21101/cejph.a7818.
10
Economic effects of dietary salt reduction policies for cardiovascular disease prevention in Japan: a simulation study of hypothetical scenarios.日本预防心血管疾病的膳食减盐政策的经济影响:假设情景的模拟研究
Front Nutr. 2023 Nov 9;10:1227303. doi: 10.3389/fnut.2023.1227303. eCollection 2023.

本文引用的文献

1
Analysing the large decline in coronary heart disease mortality in the Icelandic population aged 25-74 between the years 1981 and 2006.分析 1981 年至 2006 年间冰岛 25-74 岁人群中心血管疾病死亡率的大幅下降。
PLoS One. 2010 Nov 12;5(11):e13957. doi: 10.1371/journal.pone.0013957.
2
Will cardiovascular disease prevention widen health inequalities?心血管疾病预防会扩大健康不平等吗?
PLoS Med. 2010 Aug 24;7(8):e1000320. doi: 10.1371/journal.pmed.1000320.
3
An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort study.QRISK2 心血管疾病风险评分的独立和外部验证:一项前瞻性开放队列研究。
BMJ. 2010 May 13;340:c2442. doi: 10.1136/bmj.c2442.
4
Cardiovascular risk factor trends and potential for reducing coronary heart disease mortality in the United States of America.美国心血管风险因素趋势及降低冠心病死亡率的潜力。
Bull World Health Organ. 2010 Feb;88(2):120-30. doi: 10.2471/BLT.08.057885. Epub 2009 Dec 8.
5
Removing industrial trans fat from foods.去除食品中的工业反式脂肪。
BMJ. 2010 Apr 15;340:c1826. doi: 10.1136/bmj.c1826.
6
Population strategies to decrease sodium intake and the burden of cardiovascular disease: a cost-effectiveness analysis.降低钠摄入量和减少心血管疾病负担的人口策略:成本效益分析。
Ann Intern Med. 2010 Apr 20;152(8):481-7, W170-3. doi: 10.7326/0003-4819-152-8-201004200-00212. Epub 2010 Mar 1.
7
Projected effect of dietary salt reductions on future cardiovascular disease.预计减少饮食盐摄入量对未来心血管疾病的影响。
N Engl J Med. 2010 Feb 18;362(7):590-9. doi: 10.1056/NEJMoa0907355. Epub 2010 Jan 20.
8
Thirty-five-year trends in cardiovascular risk factors in Finland.芬兰心血管危险因素 35 年趋势变化
Int J Epidemiol. 2010 Apr;39(2):504-18. doi: 10.1093/ije/dyp330. Epub 2009 Dec 3.
9
Health effects of trans-fatty acids: experimental and observational evidence.反式脂肪酸对健康的影响:实验与观察证据
Eur J Clin Nutr. 2009 May;63 Suppl 2:S5-21. doi: 10.1038/sj.ejcn.1602973.
10
Advancing the 'science of delivery' of health promotion: not just the 'science of discovery'.推进健康促进的“传播科学”:而非仅仅是“发现科学”。
Health Promot Int. 2009 Mar;24(1):1-5. doi: 10.1093/heapro/dap003.